IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock?

16.07.25 15:42 Uhr

Werte in diesem Artikel
Aktien

137,85 EUR -2,60 EUR -1,85%

78,50 EUR 1,00 EUR 1,29%

Indizes

6.295,1 PKT -2,3 PKT -0,04%

IQVIA Holdings Inc. IQV will release its second-quarter 2025 results on July 22, before market open.The Zacks Consensus Estimate for IQV’s earnings for the soon-to-be-reported quarter has been revised upward by 4.6% year over year to $2.76 per share. Meanwhile, the Zacks Consensus Estimate for revenues is pegged at $3.96 billion, which indicates a rise of 3.8% year over year.IQV has a decent earnings surprise history, having surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 1.7%.IQVIA Holdings Inc. Price and EPS Surprise IQVIA Holdings Inc. price-eps-surprise | IQVIA Holdings Inc. QuoteIQVIA’s Q2 ExpectationsResearch and Development Solutions (“R&DS”) revenues are expected to be $2.2 billion, hinting at a 2% rise from the year-ago reported figure. The continued growth of R&DS forward-looking indicators, such as qualified pipeline, RFP flow and backlog, is expected to have fueled this segment’s revenue growth.Our estimate for revenues from Technology and Analytics Solutions is pegged at $1.58 billion, indicating a 5.5% rise on a year-over-year basis. Robust demand for integrated solutions that combine information, analytics and services is likely to have improved the segment’s revenues.Our estimate for Contract Sales and Medical solutions’ revenues is pegged at $181.9 million, implying 5.8% growth from the year-ago quarter’s actual.Our estimate for the first quarter’s adjusted EBITDA is pegged at $899.4 million, suggesting 1.4% year-over-year growth. A strong top line and price discipline are expected to have driven the bottom line.What Our Model Says About IQVOur proven model does not conclusively predict an earnings beat for IQVIA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.IQV has an Earnings ESP of -0.26% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Stocks to ConsiderHere are a few stocks from the broader Business Services sector, which, according to our model, have the right combination of elements to beat on earnings this season:Veralto Corporation VLTO: The Zacks Consensus Estimate for the company’s second-quarter 2025 revenues is pegged at $1.34 billion, indicating a 4.3% rise year over year. For earnings, the consensus mark is pegged at 89 cents per share, suggesting a 4.7% increase from the year-ago quarter’s reported figure. The company beat the consensus estimate in each of the past four quarters, with an average surprise of 6.4%. (See Zacks Earnings Calendar to stay ahead of market-making news.)VLTO currently has an Earnings ESP of +1.55% and a Zacks Rank of 2.  Equifax EFX: The Zacks Consensus Estimate for the company’s second-quarter 2025 revenues is pegged at $1.5 billion, implying a 5.9% rise year over year. For earnings, the consensus mark is pegged at $1.92 per share, suggesting a 5.5% increase from the year-ago quarter’s reported figure. The company beat the consensus estimate in each of the past four quarters, with an average surprise of 4.2%.EFX currently has an Earnings ESP of +1.46% and a Zacks Rank of 3.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Equifax, Inc. (EFX): Free Stock Analysis Report IQVIA Holdings Inc. (IQV): Free Stock Analysis Report Veralto Corporation (VLTO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: IQVIA und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf IQVIA

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf IQVIA

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu IQVIA Holdings Inc Registered Shs

Wer­bung

Analysen zu IQVIA Holdings Inc Registered Shs

DatumRatingAnalyst
09.10.2018IQVIA BuyUBS AG
02.10.2018IQVIA OutperformRobert W. Baird & Co. Incorporated
25.07.2018IQVIA BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
09.10.2018IQVIA BuyUBS AG
02.10.2018IQVIA OutperformRobert W. Baird & Co. Incorporated
25.07.2018IQVIA BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IQVIA Holdings Inc Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen